Although the expression of multiple OXPHOS genes is downregulated in skeletal muscle of patients with diabetes [9], and OXPHOS activity is reduced in diabetic and insulin-resistant individuals, we did not find evidence that OXPHOS genes lie near genetic variants that affect T2D risk or related glycemic traits. This evidence concerns the gene INS and type 2 diabetes mellitus.